PROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-α MEDIATES HIGH-FAT, DIET-ENHANCED DAILY OSCILLATION OF PLASMINOGEN ACTIVATOR INHIBITOR-1 ACTIVITY IN MICE

REFERENCES

• Andreotti F, Davies GJ, Hackett DR, Khan MI, De Bart AC, Aber VR, Maseri A, Kluft C. (1988). Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. Am. J. Cardiol. 62:635–637.
   PubMed Web of Science ®Google Scholar
• Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. (1998). Altered constitutive expression of fatty acid metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor-alpha (PPAR-alpha). J. Biol. Chem. 273:5678–5684.
   PubMed Web of Science ®Google Scholar
• Bergheanu SC, Pons D, Jukema JW, van der Hoeven BL, Liem S-S, Vandenbroucke JP, Rosendaal FR, le Cessie S, Schalij MJ, van der Bom JG. (2009). Myocardial infarction occurs with a similar pattern in the 4G/5G versions of plasminogen activator inhibitor-1. Chronobiol. Int. 26:637–652.
   PubMed Web of Science ®Google Scholar
• Braissant O, Foufellie F, Scotto C, Dauca M, Wahli W. (1996). Differential expression of Peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -ß and -γ in the adult rat. Endocrinology 137:354–366.
   PubMed Web of Science ®Google Scholar
• Braunwald E. (1995). Morning resistance to thrombolytic therapy. Circulation 91:1604–1606.
   PubMed Web of Science ®Google Scholar
• Chen JG, Li X, Huang HY, Liu HL, Liu DG, Song TJ, Ma CG, Ma D, Song HY, Tang QQ. (2006). Identification of a peroxisome proliferator responsive element (PPRE)-like cis-element in mouse plasminogen activator inhibitor-1 gene promoter. Biochem. Biophys. Res. Commun. 347:821–826.
   PubMedGoogle Scholar
• Dart AM, Chin-Dusting JP. (1999). Lipids and the endothelium. Cardiovasc. Res. 43:308–322.
   PubMed Web of Science ®Google Scholar
• Desvergne B, Wahli W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr. Rev. 20:649–688.
   PubMed Web of Science ®Google Scholar
• Fujita M, Franklin D. (1987). Diurnal changes in coronary blood flow in conscious dogs. Circulation 76:488–491.
   PubMed Web of Science ®Google Scholar
• Geppert A, Graf S, Beckmann R, Hornykewycz S, Schuster E, Binder BR, Huber K. (1998). Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. Arterioscler. Thromb. Vasc. Biol. 18:1634–1642.
   PubMed Web of Science ®Google Scholar
• Huber K, Rosc D, Resch I, Schuster E, Glogar DH, Kaindl F, Binder BR. (1988). Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction. Thromb. Haemost. 60:72–376.
   Google Scholar
• Kim J, Matsunaga N, Koyanagi S, Ohdo S. (2009). Clock gene mutation modulates the cellular sensitivity to genotoxic stress through altering the expression of N-methylpurine DNA glycosylase gene. Biochem. Pharmacol. 78:1075–1082.
   PubMed Web of Science ®Google Scholar
• Kudo T, Nakayama E, Suzuki S, Akiyama M, Shibata S. (2004). Cholesterol diet enhances daily rhythm of Pai-1 mRNA in the mouse liver. Am. J. Physiol. Endocrinol. Metab. 287:E644–E651.
   PubMed Web of Science ®Google Scholar
• Lee C, Etchegaray JP, Cagampang FR, Loudon AS, Reppert SM. (2001). Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107:855–867.
   PubMed Web of Science ®Google Scholar
• Lindeman JH, Pijl H, Toet K, Eilers PH, van Ramshorst B, Buijs MM, van Bockel JH, Kooistra T. (2007). Human visceral adipos e tissue and the plasminogen activator inhibitor type 1. Int. J. Obes. 31:1671–1679.
   Google Scholar
• Lundåsen T, Hunt MC, Nilsson LM, Sanyal S, Angelin B, Alexson SE, Rudling M. (2007). PPARα is a key regulator of hepatic FGF21. Biochem. Biophys. Res. Commun. 360:437–440.
   PubMed Web of Science ®Google Scholar
• Maemura K, de la Monte SM, Chin MT, Layne MD, Hsieh CM, Yet SF, Perrella MA, Lee ME. (2000). CLIF, a novel cycle-like factor, regulates the circadian oscillation of plasminogen activator inhibitor-1 gene expression. J. Biol. Chem. 275:36847–36851.
   PubMed Web of Science ®Google Scholar
• Mavri A, Bastelica D, Staels B, El Ayachi S, Juhan-Vague I, Alessi MC. (2004). PPARα deficiency does not modify age dependency but prevents HFD increase in plasma plasminogen activator inhibitor (PAI)-1 as well as insulin resistance. Thromb. Haemost. 91:1051–1052.
   PubMedGoogle Scholar
• McNamara P, Seo SB, Rudic RD, Sehgal A, Chakravarti D, FitzGerald GA. (2001). Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 105:877–889.
   PubMed Web of Science ®Google Scholar
• Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR. (2000). Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 141:4021–4031.
   Google Scholar
• Muller JE, Ludmer PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. (1987). Circadian variation in the frequency of sudden cardiac death. Circulation 75:131–138.
   PubMed Web of Science ®Google Scholar
• Mussoni L, Mannucci L, Sirtori M, Camera M, Maderna P, Sironi L, Tremoli E. (1992). Hypertriglyceridemia and regulation of fibrinolytic activity. Arterioscler. Thromb. 12:19–27.
   PubMedGoogle Scholar
• Nakamura K, Inoue I, Takahashi S, Komoda T, Katayama S. (2008). Cryptochrome and period proteins are regulated by the CLOCK/BMAL1 gene: crosstalk between the PPARs/RXRalpha-regulated and CLOCK/BMAL1-regulated systems. PPAR Res. (www.hindawi.com/journals/ppar/2008/348610.html).
   PubMedGoogle Scholar
• Oishi K, Ohkura N, Wakabayashi M, Shirai H, Sato K, Matsuda J, Atsumi G, Ishida N. (2006). CLOCK is involved in obesity-induced disordered fibrinolysis in ob/ob mice by regulating PAI-1 gene expression. J. Thromb. Haemost. 4:1774–1780.
   PubMed Web of Science ®Google Scholar
• Oishi K, Shirai H, Ishida N. (2007). Identification of the circadian clock-regulated E-box element in the mouse plasminogen activator inhibitor-1 gene. J. Thromb. Haemost. 5:428–431.
   PubMed Web of Science ®Google Scholar
• Oishi K, Uchida D, Ishida N. (2008). Circadian expression of FGF21 is induced by PPARalpha activation in the mouse liver. FEBS Lett. 582:3639–3642.
   PubMed Web of Science ®Google Scholar
• Oishi K, Koyanagi S, Matsunaga N, Kadota K, Ikeda E, Hayashida S, Kuramoto Y, Shimeno H, Soeda S, Ohdo S. (2010). Bezafibrate induces plasminogen activator inhibitor-1 gene expression in a CLOCK-dependent circadian manner. Mol. Pharmacol. 78:135–141.
   PubMedGoogle Scholar
• Oubina MP, de Las Heras N, Vazquez-Perez S, Cediel E, Sanz-Rosa D, Ruilope LM, Cachofeiro V, Lahera V. (2002). Valsartan improves fibrinolytic balance in atherosclerotic rabbits. J. Hypertens. 20:303–310.
   PubMed Web of Science ®Google Scholar
• Peters JM, Hennuyer N, Staels B, Fruchart JC, Fievet C, Gonzalez FJ, Auwerx, J. (1997). Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor-deficient mice. J. Biol. Chem. 272:27307–27312.
   PubMed Web of Science ®Google Scholar
• Portaluppi F, Touitou Y, Smolensky MH. (2008). Ethical and methodological standards for laboratory and medical biological rhythm research. Chronobiol. Int. 25:999–1016.
   PubMed Web of Science ®Google Scholar
• Schoonjans K, Staels B, Auwerx J. (1996). The peroxisome proliferator-activated receptors (PPARs) and their effects on lipid metabolism and adipocyte differentiation. Biochim. Biophys. Acta 1302:93–109.
   PubMed Web of Science ®Google Scholar
• Singletary JH, Chan D, Samani NJ, Chong NW. (2008). The canonical E-box motif: a target for glucocorticoid action that drives rhythmic mouse Pai-1 transcription in vitro. Gene 420:42–47.
   PubMed Web of Science ®Google Scholar
• Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. (2003). A new euglobulin clot lysis assay for global fibrinolysis. Thromb. Res. 112:329–337.
   PubMedGoogle Scholar
• Strandberg L, Lawrence D, Ny T. (1988). The organization of the human plasminogen activator inhibitor-1 gene. Implications on the evolution of the serine-protease inhibitor family. Eur. J. Biochem. 176:609–616.
   PubMedGoogle Scholar
• Tremoli E, Camera M, Maderna P, Sironi L, Prati L, Colli S, Piovella F, Bernini F, Corsini A, Mussoni L. (1993). Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon. Arterioscler. Thromb. 13:338–346.
   PubMed Web of Science ®Google Scholar
• Zeiher AM, Drexler H, Wollschlager H, Just H. (1991). Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391–401.
   PubMed Web of Science ®Google Scholar